Frederick Chite MB ChB. M.D. FASCO. Fellow ECSACOP

Join us in advancing thoracic malignancies care worldwide and improving survivorship, screening, staging, diagnostics, therapies and research in #lungcancer #cancers #Thoraciccancers @Intercancer @IASLC @myESMO @JCO_ASCO @JCOGO_ASCO @ASCO @JTOonline @CANCERKESHO @AORTIC_AFRICA

@NCIKenya @DrEliasMelly Congratulations @DrEliasMelly

The Chairman and Board of Trustees of the National Cancer Institute of Kenya is pleased to announce the appointment of @DrEliasMelly as the Chief Executive Officer with effect from 1st May 2026. ncikenya.go.ke/blogs/the-nati…

@CANCERKESHO @AORTIC_AFRICA @ASCO @myESMO @NCIKenya @KenyaMedics_KMA kesho-kenya.org/conference/

Dear Colleagues, Welcome to the 9th Kenya International Cancer Conference, under the theme “Equity, Excellence, and Sustainable Impact in Cancer Care.” November 19-21st 2026 Mombasa, KE @CANCERKESHO @AORTIC_AFRICA @ASCO @myESMO @NCIKenya @KenyaMedics_KMA kesho-kenya.org/conference/

Only a few days to go! Register for our second joint monthly MDT with the AFROC project this year, on April 9, 2026, from 4 - 5 PM EAT. We have two case presentations by Dr. Marina Planelles and Dr. Leanne Prodehl. @AORTIC_AFRICA @CANCERKESHO 1/2

For our 2nd joint monthly MDT with the AFROC project this year, on April 9, 2026, from 4 - 5 PM EAT, we have 2 case presentations by Dr. Marina Planelles & Dr. Leanne Prodehl. Our rich panel of discussants includes Dr. Maria Alsina, Dr. Uzayr Khan, & Prof. Florian Lordick 1/2

@blair_kizza Congratulations

From Uganda to the U.S. residency Match. 🇺🇬➡️🇺🇸 I officially MATCHED into residency.

Join us on Monday March 16, 2026, from 4 - 5 pm as we talk about Hodgkin's Lymphoma in our virtual multi-disciplinary Tumor board. Our CEO/PI, Prof. Chite Asirwa, MD, FASCO, (@ChiteDoc ) will lead the discussion in this webinar. 1/2

Did you know you can use your cover from @PacisInsurance, M-TIBA, @kenbright_ke, @BritamEA, @KENYANALLIANCE, @First_Assurance, @sanlam, and @AAR_Insurance to access cancer screening, diagnostic testing, treatment, palliative care, & pain management services at our clinic? 1/2

Only one day to go! Our first joint monthly MDT of the year with the AFROC project is on March 5, 2026, from 4 - 5 PM EAT. We have two case presentations by Dr. Gayathri Raveendran and Dr. Laura Predel. @myESMO @ASCO @CANCERKESHO @AORTIC_AFRICA 1/2

Only a few days to our first joint monthly MDT of the year with the AFROC project on March 5, 2026, from 4 - 5 PM EAT! We have two case presentations by Dr. Gayathri Raveendran (@ga_ya3) and Dr. Laura Predel. @CANCERKESHO @AORTIC_AFRICA @myESMO @ASCO 1/2

We are excited for our first joint monthly MDT of the year with the AFROC project on March 5, 2026, from 4 - 5 PM EAT. We'll have two case presentations by Dr. Gayathri Raveendran and Dr. Laura Predel. @CANCERKESHO @AORTIC_AFRICA @myESMO @ASCO 1/2

@andrewsuleh true & optimal diagnostics and cancer services.

All is not well in the health sector, let avoid the ostrich mentality in responding to concerns raised about our health care financing system, it is a hindrance to the timely provision if emergency services.

Celebrating James Chih-Hsin Yang and his lasting impact on JTO as an Associate Editor since 2010. Thank you! #JTO20

Palbociclib for Hormone-Receptor–Positive, HER2-Positive Advanced Breast Cancer | New England Journal of Medicine nejm.org/doi/full/10.10… NEW SoC ALERT! @Intercancer

New in @JAMAInternalMed: Bressman et al. argue clinical AI should be regulated like clinicians, not like devices. This is spot on. AI is not a pacemaker; it doesn't fit the "Software as a Medical Device" mold. It's not static, not narrow, and not a one-time review. It practices medicine. What the authors propose is licensure: prelicensure validation, supervised clinical pilots, defined scope of practice, continuing competency, discipline boards, malpractice accountability. I agree with this 100%. And it correctly reframes the entire regulatory conversation. The question isn't "is this a safe device?", it's "is this a competent practitioner?" jamanetwork.com/journals/jamai…

In our #Precisionmedicine series, Please join @Intercancer as we break down #NGS over the next 7 episodes through our MDTs platform. #NGS #Individualizedcare #CancerResearch #cancertreatment #cancercare #QualityEducation #LMIC #prevention #treatments #CURE #Translational

Join @Intercancer on our bi-weekly MDTs and Patient care and management series. #Myeloma @multiple #QualityEducation #optimalcare #treatment #survivorshipcare #palliativecare #training #PatientSafety #PatientCare #patientFirst #Diagnostics #ClinicalTrials @CANCERKESHO @NCIKenya

Subscribe to our bi-weekly CPD-accredited virtual multi-disciplinary tumor board today! Visit intercancer.com/vtb or email education@intercancer.com 2/2